NCT01975324View on ClinicalTrials.gov

A New Medicine to Treat Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Non Arteritic Ischemic Optic Neuropathy
Interventions
DRUG

dalfampridine

dalfampridine 10 mgs or placebo twice a day for two weeks, wash out period of two weeks, dalfampridine 10mgs or placebo twice a day for two weeks

DRUG

Placebo

placebo (sugar pill) twice a day for two weeks

Trial Locations (1)

19107

Neuro-Ophthalmologic Associates, PC, Philadelphia

Sponsors

Collaborators (1)

Acorda Therapeutics
All Listed Sponsors
collaborator

Acorda Therapeutics

INDUSTRY

lead

Neuro-Ophthalmologic Associates, PC

OTHER